NTI ASX Chart
Snapshot
Neurotech International Limited is a medical device and solutions company conducting clinical studies to assess the neuro-protective, anti-inflammatory and neuro-modulatory activities of our proprietary NTI/Dolce cannabis strains. NTI is currently utilising NTI164 in a study to treat paediatric Autism Spectrum Disorder (ASD) and commercialising Mente, the world's first home therapy that is clinically proven to increase engagement and improve relaxation in autistic children with elevated Delta band brain activity.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | +125.54% |
vs ASX 200 (1yr) | +117.16% |
Key Fundamentals
Shares Issued | |
Sector | Healthcare |
Similar Companies | SDI / QTM / IMR |
EPS | -$0.006 |
DPS | $0.00 |
Book Value Per Share | $0.004 |
Broker Consensus
Please see the Broker Consensus page.
Latest Neurotech International Ltd News
Announcements
Corporate Overview
Corporate Details
Head Office | Nedlands WA 6009 |
Website | www.neurotechinternational.com |
Registry | Automic Group |
Auditor | BDO Audit (WA) Pty Ltd |
Date Listed | 4 Nov 2016 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
28/08/2024 | Report (Prelim) |
28/08/2024 | Report (Annual) |
20/09/2024 | Report (Annual) |
25/02/2025 | Report (Interim) |
Former Company Names
- Neurotech International Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
NTI directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of NTI directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Merchant Funds Management Pty Ltd | 30/11/2023 | 54,424,419 | 6.03 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
30-11-23 | Merchant Funds Management Pty Ltd | 18,022,192 | 5.01 | 6.03 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.040 | 30 June |
2022 | $0.070 | 30 June |
2021 | $0.053 | 30 June |
2020 | $0.008 | 30 June |
2019 | $0.018 | 28 June |
2018 | $0.160 | 29 June |
2017 | $0.250 | 28 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.